Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?

Author:

Majewski Marek1,Torres Kamil2,Mertowska Paulina3ORCID,Mertowski Sebastian3ORCID,Korona-Głowniak Izabela4ORCID,Korulczyk Jan2,Zgodziński Witold5,Grywalska Ewelina3ORCID

Affiliation:

1. 2nd Department of General, Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, 20-081 Lublin, Poland

2. Chair and Department of Didactics and Medical Simulation, Medical University of Lublin, 20-093 Lublin, Poland

3. Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland

4. Department of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland

5. 1st Department of General and Transplant Surgery and Clinical Nutrition, Medical University of Lublin, 20-090 Lublin, Poland

Abstract

Gastric cancer is one of the five most common types of cancer worldwide. Due to the heterogeneous course and the involvement of many risk factors, its treatment and diagnosis is an important challenge for modern medicine. Recent studies have emphasized the i role of Toll-like receptors (TLRs) expressed on selected cells of the immune system in the pathogenesis of gastric cancer. The aim of this study was to determine the prevalence of TLR2 on T lymphocytes, B lymphocytes, monocytes, and dendritic cells in patients diagnosed with gastric cancer, with particular emphasis on the stage of the disease. Based on the obtained results, we have shown that patients with gastric cancer are characterized by a higher percentage of all tested populations of peripheral blood immune cells expressing TLR2 in relation to patients from the control group. Moreover, a detailed analysis of the collected results showed a significant link between TLR2 and the stage of the disease.

Funder

Medical University of Lublin

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference30 articles.

1. (2023, January 08). Cancer Tomorrow. Available online: https://gco.iarc.fr/tomorrow/en/dataviz/isotype.

2. Stomach Cancer Statistics (2023, January 08). WCRF International. Available online: https://www.wcrf.org/cancer-trends/stomach-cancer-statistics/.

3. Epidemiology of Stomach Cancer;Ilic;World J. Gastroenterol.,2022

4. (2023, January 08). Stomach (Gastric) Cancer Key Statistics. Available online: https://www.cancer.org/cancer/stomach-cancer/about/key-statistics.html.

5. (2023, January 08). Cancer of the Stomach—Cancer Stat Facts, Available online: https://seer.cancer.gov/statfacts/html/stomach.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3